Success Stories: EB-1A Approved for a Postdoctoral Research Associate in Texas in the Field of Biomedical Science
We Received EB1-A (Alien of Extraordinary Ability) Approval on November 7th, 2014 for a Postdoctoral Research Associate inTexas in the Field of Biomedical Science (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Texas
Approval Notice Date: November 7th, 2014
Processing Time: 29 Days (9 Days after upgrading to Premium Processing)
In this case, the client that we had the pleasure of working with was a Postdoctoral Research Associate from China in the field of Biomedical Science. His work had resulted in at least 26 peer-reviewed scientific articles and numerous presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 235 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also reviewed 59 manuscripts for at least 8 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “Allowing [client] to continue to base his research in the United States, where he can flourish and be supported by an active academic community, will ensure that the whole medical and scientific community can continue to benefit from [client]’s talent and insight into these severe [diseases]. Alongside this there remains the value of [client]’s work to those [patients] for whom his findings will be highly significant and improve their quality of life inestimably.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Biomedical Science, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 29 days.